A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1997
12/31/1997	WO1997049418A1 Methods of promoting hematopoiesis using derivatives of human chorionic gonadotropin
12/31/1997	WO1997045528A3 Mammalian tolloid-like gene and protein
12/31/1997	WO1997044454A3 Human phospholipase inhibitor
12/31/1997	WO1997041226A3 Polynucleotides encoding the transcriptional repressor gcf2 of the epidermal growth factor receptor
12/31/1997	CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants
12/31/1997	CA2258564A1 Brain glycogen phosphorylase cancer antigen
12/31/1997	CA2257180A1 Method of identifying cytochrome p450
12/31/1997	CA2230088A1 A novel hypertension related calcium regulated gene (hcarg)
12/30/1997	US5703057 Expression library immunization
12/30/1997	US5703056 Monitoring therapy
12/30/1997	US5703055 Generation of antibodies through lipid mediated DNA delivery
12/30/1997	US5703054 Oligonucleotide modulation of protein kinase C
12/30/1997	US5703051 Therapeutic uses of melanin
12/30/1997	US5702908 Interruption of binding of MDM2 and p53 protein and therapeutic application thereof
12/30/1997	US5702903 Detecting gene that has been amplified or detecting increased expression of gene products
12/30/1997	US5702890 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
12/30/1997	US5702384 Apparatus for gene therapy
12/29/1997	EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics
12/29/1997	EP0814154A2 Recombinant alphavirus vectors
12/29/1997	EP0813606A2 Method of purification of recombinant viral vectors containing a therapeutic gene
12/29/1997	EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
12/29/1997	EP0813539A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
12/29/1997	EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders
12/29/1997	EP0813419A1 Modulators of regulatory proteins
12/29/1997	EP0813365A1 Immunoisolation
12/29/1997	EP0705270B1 Chemically modified oligonucleotide for site-directed mutagenesis
12/24/1997	WO1997048815A2 Method for enhancing gene transfer
12/24/1997	WO1997048806A1 Gene therapy for obesity
12/24/1997	WO1997048805A1 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF
12/24/1997	WO1997048803A1 Human protein kinase c inhibitor homolog
12/24/1997	WO1997048802A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG
12/24/1997	WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins
12/24/1997	WO1997048795A2 Compositions and methods for treating specific gene expression-related diseases and disorders in humans
12/24/1997	WO1997048727A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus
12/24/1997	WO1997048724A2 Human metabotropic glutamate receptor
12/24/1997	WO1997048721A1 Hodgkin's disease associated molecules and uses thereof
12/24/1997	WO1997048720A1 Nucleic acid molecule for enhancing gene expression
12/24/1997	WO1997048485A1 Method for providing dense particle compositions for use in transdermal particle delivery
12/24/1997	WO1997048419A1 Gene therapy for obesity
12/24/1997	WO1997044065A3 Device and method for encapsulated gene therapy
12/24/1997	WO1997043404A3 Ribozyme variants with improved catalytic activity under low magnesium conditions
12/24/1997	CN1168698A Recombinant proteins of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines
12/24/1997	CN1168696A RNA component of telomerase
12/24/1997	CN1168695A Inhibitor of stem cell proliferation and uses thereof
12/24/1997	CA2294433A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus
12/24/1997	CA2258755A1 Gene therapy for obesity
12/24/1997	CA2258573A1 Hodgkin's disease associated molecules and uses thereof
12/24/1997	CA2258504A1 Gene therapy for obesity
12/24/1997	CA2257880A1 Method for enhancing gene transfer
12/24/1997	CA2257855A1 Human thymosin .beta.15 gene, protein and uses thereof
12/24/1997	CA2257847A1 Polynucleotides from human fetal brain encoding secreted proteins
12/24/1997	CA2257528A1 Human protein kinase c inhibitor homolog
12/24/1997	CA2257130A1 Human camp-dependent protein kinase inhibitor homolog
12/24/1997	CA2246751A1 Human metabotropic glutamate receptor
12/23/1997	US5700928 Polynucleotide encoding saliva binding protein
12/23/1997	US5700923 Rigid linker comprising at least one non-nucleotidic unit, flanked by first and second flanking regions of at least four contiguous, covalently-linked nucleotides; complementary to target region on substrate rna molecule
12/23/1997	US5700922 PNA-DNA-PNA chimeric macromolecules
12/23/1997	US5700907 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
12/23/1997	US5700691 Culturing cd34+hematopoietic progenitor cells
12/23/1997	US5700690 Vector comprising fibroblast specific gene promoter sequence linked to dna sequence of interest
12/23/1997	US5700638 Cell death regulator
12/18/1997	WO1997047772A2 Ataxia-telangiectasia: mutations in the atm gene
12/18/1997	WO1997047759A1 Recombinant adeno-associated viral vectors
12/18/1997	WO1997047757A1 Generating replicating molecules in vivo
12/18/1997	WO1997047732A2 Hexameric fusion proteins and uses therefor
12/18/1997	WO1997047646A1 Helicobacter pylori adhesin binding group antigen
12/18/1997	WO1997047638A1 Cellular injury response element and uses thereof
12/18/1997	WO1997047637A1 Phosphotriester oligonucleotides, amidites and method of preparation
12/18/1997	WO1997047358A1 Synthetic hepatitis c genes
12/18/1997	WO1997047326A1 INHIBITION OF Ii SYNTHESIS
12/18/1997	WO1997047316A1 Screening methods for compounds useful in the regulation of body weight
12/18/1997	WO1997047306A1 δ-ERYTHROID KRÜPPEL-LIKE FACTORS AND METHODS OF USE
12/18/1997	WO1997047271A2 Cellular vaccines and immunotherapeutics and methods for their preparation
12/18/1997	WO1997047197A1 Compositions and methods for administering borrelia dna
12/18/1997	WO1997035015A3 Tyrosine-phosphatase-related protein
12/18/1997	WO1997029183A3 Methods and compositions for transforming dendritic cells and activating t cells
12/18/1997	CA2258553A1 Cellular injury response element and uses thereof
12/18/1997	CA2258082A1 Cellular vaccines and immunotherapeutics and methods for their preparation
12/18/1997	CA2258016A1 Compositions and methods for administering borrelia dna
12/18/1997	CA2257916A1 Generating replicating molecules in vivo
12/18/1997	CA2257861A1 Hexameric fusion proteins and uses therefor
12/18/1997	CA2257857A1 Screening methods for compounds useful in the regulation of body weight
12/18/1997	CA2257137A1 Synthetic hepatitis c genes
12/17/1997	EP0812916A2 Cathepsin k gene
12/17/1997	EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family
12/17/1997	EP0812360A1 Human geranylgeranyl pyrophosphate synthetase
12/17/1997	EP0812356A1 Prostate-specific membrane antigen and uses thereof
12/17/1997	EP0812355A2 Agent for treating tumours and other hyperplasia
12/17/1997	EP0812352A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras
12/17/1997	EP0812209A1 Cochleate phospholipids in drug delivery
12/17/1997	EP0812204A1 Codominance-mediated toxins
12/17/1997	EP0716570A4 Genetically modified human hematopoietic stem cells and their progeny
12/17/1997	EP0458901B1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
12/16/1997	US5698763 Transgenic animals lacking prion proteins
12/16/1997	US5698687 Rna molecule containing modified nucloside
12/16/1997	US5698686 Yeast telomerase compositions
12/16/1997	US5698531 Delivering a dna sequence encoding a therapeutic or diagnostic protein by catheterization to a discrete blood vessel segment using genetically engineered or normal cells or vector systems; drug delivery
12/16/1997	US5698443 Tissue specific viral vectors
12/16/1997	US5698439 Novel malignant cell type markers of the interior nuclear matrix
12/16/1997	US5698396 Method for identifying auto-immunoreactive substances from a subject

1 ... 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 ... 870